Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
Robert M Berman1, Michael E Thase2, Madhukar H Trivedi3, James A Hazel4, Sabrina Vogel Marler5, Robert D McQuade6, William Carson7, Ross A Baker8, Ronald N Marcus91Neuroscience Global Clinical Research Bristol-Myers Squibb, Wallingford, CT, USA; 2Department of Psychiatry, University of Pennsylvania...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2011-05-01
|
| Серии: | Neuropsychiatric Disease and Treatment |
| Online-ссылка: | http://www.dovepress.com/long-term-safety-and-tolerability-of-open-label-aripiprazole-augmentat-a7518 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|